Categories AlphaGraphs, Earnings, Health Care

Key highlights from AngioDynamics (ANGO) Q4 2020 earnings results

AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020.

  • Net loss for the fourth quarter was $156 million, or $4.10 per share, compared to net loss of $165.8 million, or $4.37 per share in the fourth quarter of 2019
  • Net sales decreased 41% to $58.3 million
  • Capital expenditures during the quarter was $1.5 million

Looking forward to listening to management/analysts comments on Q4 results? Stay tuned here for AngioDynamics Q4 2020 earnings call transcript

AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results
Also Read:  Catalent Inc (CTLT) Q4 2020 Earnings Call Transcript

Most Popular

Palantir Technologies (PLTR) to start trading tomorrow through direct listing

The IPO market witnessed a boom in 2020, despite the pandemic weakening the macro environment. Many tech companies have witnessed a blockbuster listing this year and few more tech firms

Micron (MU) Q4 earnings, revenue top expectations

Micron Technology Inc. (NASDAQ: MU) reported strong earnings and revenue growth for the fourth quarter of 2020, benefitting from the pandemic-driven digital transformation spree. However, the company's stock dropped during

After a strong year thus far, Zynga (ZNGA) appears well-positioned for 2021 as well

Mobile game company Zynga Inc. (NASDAQ: ZNGA) has seen its stock gain 49% since the beginning of this year. The company registered strong results in the first half of 2020